Fundraising FoxAriel Precision Medicine
Pittsburgh, US · Founded 2013 · 5 known investors
Find your way into Ariel Precision Medicine
Sign up to see every warm intro you have to Ariel Precision Medicine
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ariel Precision Medicine team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Ariel Precision Medicine offers an AI-driven platform that integrates genomic and clinical data (including EHR/EMR records, lab results, and scientific literature) to produce peer-reviewed, evidence-based reports. It serves clinicians diagnosing complex diseases and therapeutics developers seeking target discovery and patient stratification.
Founders & leadership
Ariel Precision Medicine was founded in 2013 by Jessica Gibson and David Whitcomb.
Board
Investors · 5
Reported raises · per SEC filings
Form D private placements$5.4M disclosed across 2 of 3 rounds · 2016–2019
▶$5.3MraisedJul 2019 · 20 investors · BiotechnologyRule 506(b)
- David WhitcombDirector
- Hank SaffersteinDirector
- Jessica GibsonExecutive Officer, Director
- Christopher MoehleDirector
- David SmithDirector
- John T.B. MooreExecutive Officer
- Offering amount
- $8.8M
- Amount sold
- $5.3M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$125KraisedMay 2016 · 3 investors · BiotechnologyRule 506(b)
- Jessica GibsonExecutive Officer, Director
- David WhitcombDirector
- Stephan DietrichDirector
- Mary Del BradyExecutive Officer, Director
- John MooreExecutive Officer
- David SmithDirector
- Offering amount
- $780K
- Amount sold
- $125K
- First sale
- May 2016
- Incorporated
- Limited Liability Company, Pennsylvania, 2013
- Federal exemptions
- 04, 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Ariel Precision Medicine do?
- Ariel Precision Medicine offers an AI-driven platform that integrates genomic and clinical data (including EHR/EMR records, lab results, and scientific literature) to produce peer-reviewed, evidence-based reports. It serves clinicians diagnosing complex diseases and therapeutics developers seeking target discovery and patient stratification.
- Who founded Ariel Precision Medicine?
- Ariel Precision Medicine was founded by Jessica Gibson, David Whitcomb in 2013.
- Who are Ariel Precision Medicine's investors?
- Ariel Precision Medicine's investors include Creative Destruction Lab (CDL), String Ventures, The Robotics Hub, Lead Edge Capital, Robotics Hub.
- How much funding has Ariel Precision Medicine raised?
- Ariel Precision Medicine has disclosed $5.4M raised across 2 of its 3 known rounds.
- Where is Ariel Precision Medicine headquartered?
- Ariel Precision Medicine is headquartered in Pittsburgh, US.